Skip to main content
. Author manuscript; available in PMC: 2020 Nov 1.
Published in final edited form as: Exp Cell Res. 2019 Sep 9;384(1):111621. doi: 10.1016/j.yexcr.2019.111621

Table 1.

STR analysis of original tissue and cells at passages 2, 6, 9 and 13

D3S1358 TH01 D21S11 D18S51 Penta E D5S818 D13S317 D7S820 D16S539 CSF1PO Penta D vWA D8S1179 TPOX FGA AMEL
tissue 14, 16 7, 9.3 28, 29 14, 16 13, 14 11, 13 12, 14 8, 11 8, 11 11, 12 2.2, 10 14, 17 13, 14 8 23 X, Y
P2 14, 16 7, 9.3 28, 29 14, 16 13, 14 11, 13 12, 14 8, 11 8, 11 11, 12 2.2, 10 14, 17 13, 14 8 23 X, Y
P6 14, 16 7, 9.3 28, 29 14, 16 13, 14 11, 13 12, 14 8, 11 8, 11 11, 12 2.2, 10 14, 17 13, 14 8 23 X, Y
P9 14, 16 7, 9.3 28, 29 14, 16 13, 14 11, 13 12, 14 8, 11 8, 11 11, 12 2.2, 10 14, 17 13, 14 8 23 X, Y
P13 14, 16 7, 9.3 28, 29 14, 16 13, 14 11, 13 12, 14 8, 11 8, 11 11, 12 2.2, 10 14, 17 13, 14 8 23 X, Y